Geert R Kersten has bought CVM on 9 days since Jan 2020

Geert R. Kersten, Esq. is the Chief Executive Officer (CEO), Treasurer, and a Director at CEL-SCI Corporation (CVM), a clinical-stage biotechnology company focused on cancer immunotherapy, particularly its lead product Multikine for head and neck cancer.( He has served in his current leadership role since 1995 and has been with CEL-SCI since its inception in 1987, leading financing, R&D efforts, and the company's Multikine strategy over nearly four decades.(

Kersten holds an undergraduate degree in Accounting, an MBA from George Washington University, and a JD from American University, providing expertise in finance and law from prior roles at Finley & Kumble law firm and Source Capital investment banking.( As of 2025, he is approximately 66 years old and has recently engaged in insider trading at CVM, including a personal purchase of $200,000 worth of stock.( Under his leadership, CEL-SCI is pursuing global commercialization, including regulatory pathways in the U.S., Europe, and Saudi Arabia.(

Written by Perplexity from public sources.